V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190006726 | 190001598 | 0 | 68 | Palliative (P) | 2017-09-19 | 2017-09-27 | EURAMOS TRIAL | 02 | N | CISPLATIN + FLUOROURACIL | 101714061 |
| 190006727 | 190001599 | null | 63.2 | Palliative (P) | null | 2019-03-27 | EURAMOS TRIAL | N | N | FLUOROURACIL + OXALIPLATIN | 101716540 |
| 190006728 | 190001600 | 1.83 | 79.2 | Curative (C) | 2018-11-13 | 2018-11-16 | ECX | Y | N | CAPECITABINE + OXALIPLATIN | 101353381 |
| 190006730 | 190001601 | null | null | null | null | 2017-07-12 | CARBOPLATIN + RT | null | null | EVEROLIMUS | 101028538 |
| 190006735 | 190001604 | null | null | null | null | 2016-02-24 | CISPLATIN + FLUOROURACIL | null | null | ENZALUTAMIDE | 100852239 |
| 190006748 | 190001608 | 1.75 | 48.5 | Not known (9) | 2016-05-17 | 2016-05-17 | FEC 100 + DOCETAXEL | 02 | N | PACLITAXEL | 100719589 |
| 190006751 | 190001611 | 1.11 | 64.5 | Adjuvant (A) | 2019-06-05 | 2019-06-12 | AVAPRITINIB | 02 | N | TEMOZOLOMIDE | 101580044 |
| 190006752 | 190001612 | 1.54 | 65.95 | Palliative (P) | 2019-09-03 | 2019-09-11 | Cisplatin + Doxorubicin | Y | N | CISPLATIN + DOXORUBICIN | 101802901 |
| 190006754 | 190001613 | 1.56 | 95.7 | Curative (C) | null | 2017-12-11 | Dox + HD Mtx (post PAM) | 02 | null | TRIAL UNSPECIFIED | 101614028 |
| 190006758 | 190001615 | 1.68 | 58.6 | Neo-adjuvant (N) | 2016-08-16 | 2016-08-19 | OST Euramos 1 Closed Trial - AP | N | N | EOX | 100033864 |
| 190006762 | 190001617 | 1.57 | 60.8 | Palliative (P) | 2017-03-01 | 2017-03-09 | POMB/ACE | 02 | N | GEMCITABINE | 101504152 |
| 190006764 | 190001618 | 1.69 | 85 | Curative (C) | 2017-04-12 | 2017-04-25 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101164994 |
| 190006766 | 190001619 | null | null | null | null | 2017-06-04 | CISPLATIN + GEMCITABINE | null | null | CISPLATIN + GEMCITABINE | 101148070 |
| 190006768 | 190001620 | null | null | null | null | 2016-02-18 | Ifosfamide | null | null | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101011222 |
| 190006771 | 190001621 | 1.63 | 50.55 | Curative (C) | 2018-11-29 | 2018-11-30 | IMATINIB | N | N | DOXORUBICIN + METHOTREXATE | 100657374 |
| 190006772 | 190001622 | null | null | null | null | 2018-08-08 | CISPLATIN + GEMCITABINE | null | null | CISPLATIN + GEMCITABINE | 101450655 |
| 190006776 | 190001623 | null | null | Curative (C) | null | 2018-12-31 | GEMCARBO | null | null | OCTREOTIDE | 101721429 |
| 190006779 | 190001625 | null | null | null | null | 2016-12-03 | Cisplatin + Radiotherapy | null | null | CISPLATIN | 100504252 |
| 190006781 | 190001626 | 1.67 | 74 | Neo-adjuvant (N) | 2018-12-29 | 2019-01-03 | Cisplatin + Radiotherapy | 02 | N | LANREOTIDE | 101595518 |
| 190006783 | 190001627 | 1.8 | 110 | Palliative (P) | 2015-09-13 | 2015-09-27 | Cisplatin | null | null | CISPLATIN | 101329351 |
| 190006789 | 190001628 | 1 | 85 | Palliative (P) | 2021-08-19 | 2021-08-19 | Cisplatin + Etoposide (3 day) | 02 | N | CISPLATIN + FLUOROURACIL | 100137018 |
| 190006791 | 190001629 | null | null | null | null | 2016-03-26 | Cisplatin | null | null | CISPLATIN | 101559901 |
| 190006800 | 190001634 | null | null | null | null | 2017-08-14 | GemCarbo Days 1+8 | null | null | CAPECITABINE + STREPTOZOCIN | 101094021 |
| 190006819 | 190001641 | null | 76 | Neo-adjuvant (N) | 2018-10-08 | 2018-10-15 | Capecitabine + Oxaliplatin 21day | N | N | CAPECITABINE + OXALIPLATIN | 101442589 |
| 190006823 | 190001643 | 1.78 | 76.3 | Palliative (P) | 2018-12-24 | 2018-12-26 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CISPLATIN + GEMCITABINE | 101504882 |
| 190006827 | 190001645 | null | null | null | null | 2017-12-16 | EURAMOS TRIAL | null | null | CISPLATIN + ETOPOSIDE | 100586716 |
| 190006842 | 190001652 | 0 | 0 | Curative (C) | 2016-08-24 | 2016-09-05 | DOXORUBICIN | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100082623 |
| 190006844 | 190001653 | null | null | null | null | 2018-06-24 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100445431 |
| 190006847 | 190001654 | null | null | null | null | 2018-07-07 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101796737 |
| 190006853 | 190001655 | null | null | null | null | 2019-12-10 | null | null | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101813862 |
| 190006860 | 190001657 | null | null | null | null | 2020-02-18 | Carboplatin + Etoposide iv&po | null | null | OST AP | 101523346 |
| 190006866 | 190001658 | 1.51 | 58.8 | Palliative (P) | 2017-06-09 | 2017-06-16 | Cisplatin + Radiotherapy | Y | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101075297 |
| 190006869 | 190001659 | 1.53 | 60.4 | Adjuvant (A) | 2016-04-16 | 2016-04-21 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 101142086 |
| 190006871 | 190001661 | null | null | null | null | 2017-07-13 | OST Euramos 1 Closed Trial - AP | null | null | EVEROLIMUS | 101334963 |
| 190006879 | 190001664 | 1.51 | 0 | null | 2016-12-26 | 2017-01-21 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | null | TRIAL UNSPECIFIED | 100034127 |
| 190006885 | 190001669 | 1.55 | 68 | Curative (C) | 2017-01-19 | 2017-01-19 | Dox + HD Mtx (post PAM) | null | Y | CISPLATIN + DOXORUBICIN + ETOPOSIDE + MITOTANE | 101483173 |
| 190006891 | 190001672 | null | null | null | null | 2017-01-31 | MPT | null | null | CAPECITABINE + TEMOZOLOMIDE | 101311680 |
| 190006894 | 190001674 | 1.76 | 71.9 | null | 2016-10-25 | 2016-11-11 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 101097341 |
| 190006901 | 190001678 | null | null | null | null | 2019-04-19 | LANREOTIDE | null | null | CAPECITABINE | 101302082 |
| 190006902 | 190001679 | 1.87 | 86 | Curative (C) | 2020-01-24 | 2020-01-25 | ECX | 01 | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 100656991 |
| 190006912 | 190001682 | 1.73 | 77 | Curative (C) | 2020-11-21 | 2020-11-22 | Capecitabine + Oxaliplatin 21day | 02 | N | DOCETAXEL | 101585578 |
| 190006928 | 190001687 | null | null | null | null | 2017-06-14 | Cisplatin + Radiotherapy | null | null | CISPLATIN | 100324476 |
| 190006929 | 190001688 | 1.63 | 72.5 | Adjuvant (A) | 2015-10-11 | 2015-10-11 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + ETOPOSIDE | 101030233 |
| 190006933 | 190001689 | 1.75 | 62.4 | Palliative (P) | null | 2018-01-10 | Cisplatin + Etoposide po&iv 3 day | null | null | FCARBOST | 100563571 |
| 190006946 | 190001691 | 0 | 109 | Curative (C) | 2016-10-27 | 2016-11-14 | ETOPOSIDE + IFOSFAMIDE | 02 | Y | OXALIPLATIN + RALTITREXED | 100097843 |
| 190006949 | 190001692 | null | null | null | null | 2016-11-19 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | CISPLATIN + GEMCITABINE | 100485834 |
| 190006952 | 190001693 | null | null | null | null | 2017-11-20 | ECarboX | null | null | CARBOPLATIN + RT | 101693086 |
| 190006954 | 190001694 | null | null | null | null | 2020-06-22 | null | null | null | EVEROLIMUS | 101668920 |
| 190006961 | 190001697 | 0 | 48.4 | Palliative (P) | 2019-06-20 | 2019-06-25 | EW EuroEwing 2012 Arm B VDC | 02 | N | CISPLATIN + ETOPOSIDE | 101243207 |
| 190006964 | 190001699 | null | null | null | null | 2019-12-23 | CHOP R - 21 days | null | null | CABOZANTINIB | 100348099 |